Participants
eclampsia, renal, cardiac or respiratory failure, abruption, coma, hemolysis, preeclampsia
ECLAMPSIA, SYNDROME, COMA, HEMOLYSIS, PREECLAMPSIA, NONREASSURING FETAL STATUS
Patients presenting with suspected or confirmed preeclampsia between 20Patients with multifetal gestations or those presenting with a diagnosis of fetal demise, nonreassuring fetal status necessitating immediate delivery at admission, eclampsia, hemolysis, elevated liver enzymes, low platelets syndrome, renal, cardiac or respiratory failure, coma, active labor, abruption or emergent delivery for other indications were not included in the risk stratification component of the study.This study was approved by the national central ethical committee on research involving Human Subjects (CAAE: 53092916·4·2008·5411) and by each local ethical committee of the participating centers. The PREPARE trial was a hospital-wide intervention within a cluster trial. Informed consent at an individual participant level for the intervention was not deemed necessary by the ethics committee.